biochemicla markers
Showing 1 - 25 of 8,930
TTC for Early Diagnosis of Acute Myocardial Infarction at
Recruiting
- Myocardial Infarction
- TTC immersion
-
Montpellier, FranceUhmontpellier
Jun 10, 2021
Ischemic Cardiomyopathy, Diabetes Trial in Damanhur (Alpha Lipoic Acid 600 MG Oral Tablet, Placebo Tablet)
Recruiting
- Ischemic Cardiomyopathy
- Diabetes Mellitus
- Alpha Lipoic Acid 600 MG Oral Tablet
- Placebo Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 26, 2023
MDD, Epilepsy Trial (Intracranial electrodes, TMS)
Not yet recruiting
- Major Depressive Disorder
- Epilepsy
- Intracranial electrodes
- TMS
- (no location specified)
Aug 9, 2023
Primary Ovarian Insufficiency, Premature Ovarian Failure Trial in Toronto (Neupogen)
Recruiting
- Primary Ovarian Insufficiency
- Premature Ovarian Failure
-
Toronto, Ontario, CanadaTrio Fertility
Oct 31, 2023
Bone Markers in Pediatric IF
Recruiting
- Intestinal Failure
- +2 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Jun 9, 2023
Radiation Therapy, Cancer Patients, Tattooing Trial in Taichung City (Nursing care)
Completed
- Radiation Therapy
- +2 more
- Nursing care
-
Taichung City, Taiwan (r.o.c.), TaiwanChung Shan Medical University
Nov 13, 2023
Obesity Trial (Sleep restriction)
Not yet recruiting
- Obesity
- Sleep restriction
- (no location specified)
Jul 11, 2023
Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Chronic Kidney Diseases
- Empagliflozin 10 MG
- Placebo
- (no location specified)
Oct 30, 2023
Acute and Chronic Organophosphate Toxicity
Recruiting
- Neuroinflammatory Response
- +5 more
- exposure to organophosphates
-
Alexandria, EgyptAlexandria Main University Hospital
Aug 27, 2023
Ultrasound Conspicuity, and Migration of Twinkling Markers in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +2 more
- Magnetic Resonance Imaging
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Periodontal Diseases, Smoking Cessation Trial in Cairo (Minimally invasive non-surgical periodontal therapy, Conventional
Completed
- Periodontal Diseases
- Smoking Cessation
- Minimally invasive non-surgical periodontal therapy
- Conventional non-surgical periodontal therapy
-
Cairo, EgyptAin Shams University
Nov 22, 2023
Endothelial Dysfunction, Vascular Diseases, Kidney Injury Trial in Nashville (Vericiguat, Placebo)
Not yet recruiting
- Endothelial Dysfunction
- +4 more
- Vericiguat
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 11, 2023
Aging Trial in Toulouse (MRI, eye-tracking, cognitive exams)
Not yet recruiting
- Aging
- MRI
- +2 more
-
Toulouse, FranceToulouse NeuroImaging Centre (ToNIC - UMR1214 Inserm/UT3)
Sep 21, 2023
Macrosomia, Fetal, Gestational Diabetes in Pregnancy Trial in Bordeaux (Pregnant women)
Not yet recruiting
- Macrosomia, Fetal
- Gestational Diabetes Mellitus in Pregnancy
- Pregnant women
-
Bordeaux, FranceHopital Pellegrin
Sep 15, 2023
Exploration of Locally Recurrent Colorectal Cancer
Recruiting
- Locally Recurrent Colorectal Cancer
- salvage surgery
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences & Peking Un
Oct 28, 2023
Esophageal Tumor, Rectal Tumors Trial in Paris (fiducial markers placement)
Completed
- Esophageal Neoplasm
- Rectal Neoplasms
- fiducial markers placement
-
Paris, FranceUlriikka CHAPUT
Dec 2, 2022
Residual Cognitive Functions in Severe Alterations of
Completed
- Consciousness Disorder
- Cognitive Impairment
- Neurowave Group
-
Messina, ItalyIRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 27, 2023
Interleukin 6 Receptor Antagonists in Corona Virus Disease 19
Recruiting
- Corona Virus Infection
- ELISA
-
Assiut, EgyptAssiutU
Feb 2, 2023
Thrombin Generation Parameters in Patients on ECMO Support:Pilot
Recruiting
- Extracorporeal Circulation; Complications
- Extracorporeal Membrane Oxygenation Complication
- DIC markers and Thrombin Generation Parameters
-
Hong Kong, Hong KongQueen Mary Hospital
Oct 18, 2023
Retinal Detachment, Rhegmatogenous Retinal Detachment Trial in Madison (Lamivudine 300 MG, Placebo)
Not yet recruiting
- Retinal Detachment
- Rhegmatogenous Retinal Detachment
- Lamivudine 300 MG
- Placebo
-
Madison, WisconsinUniversity of Wisconsin
Sep 20, 2023
Social Phobia, Body Dysmorphic Disorder Trial in Boston, Charlestown (Cognitive-behavioral therapy)
Completed
- Social Phobia
- Body Dysmorphic Disorder
- Cognitive-behavioral therapy
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
MicroRNA Markers in Head and Neck Cancers
Active, not recruiting
- Squamous Cell Carcinoma of Head and Neck
- Tissue collection
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 1, 2023
Metabolic Biomarkers and Their Prognostic Relationship in
Not yet recruiting
- Ovarian Cancer
- No intervention
- (no location specified)
Aug 24, 2023
Autism Spectrum Disorders
Not yet recruiting
- Autism Spectrum Disorder
- inflammatory marker in autism spectrum disorder
- (no location specified)
Mar 26, 2023
The BASA Study: Breath Analysis for Severe Asthma Patients
Recruiting
- Severe Asthma
- exhaled breath analysis
-
Palermo, ItalyAOUP Policlinico Paolo Giaccone
Jul 13, 2023